Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John F. Bauer is active.

Publication


Featured researches published by John F. Bauer.


Pharmaceutical Research | 1990

Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography.

John F. Bauer; Lee Elrod; Joseph R. Fornnarino; Douglas Heathcote; Sue K. Krogh; Cathie L. Linton; Barbara Norris; John Quick

The fluoroquinolones, temafloxacin, sarafloxacin, and difloxacin, are determined in the bulk drug substances and in a variety of dosage forms using high-performance liquid chromatography (HPLC). The HPLC system used is also applicable for ciprofloxacin and norfloxacin. The procedure uses UV detection at 280 nm, which provides a linear response of the subject compounds to at least 20 µg/ml. Assay precision (RSD) values were ±1.2% or better for the bulk drugs and ranged from ±0.42 to ±2.3% for suspension, capsule, and tablet formulations. Drug recoveries were quantitative from the dosage forms tested. Sensitivity of the subject compounds is approximately 50 ng/ml (2.5 ng on column).


Journal of Pharmaceutical and Biomedical Analysis | 2000

The use of near-infrared spectroscopy to monitor the mobility of water within the sarafloxacin crystal lattice

Walter Dziki; John F. Bauer; Joseph J Szpylman; John Quick; Brian C Nichols

Near-infrared spectroscopy (NIRS) is proposed as a technique to study the mobility of water within the sarafloxacin crystal lattice. An investigation of two samples of sarafloxacin revealed that NIRS can distinguish between acceptable and unacceptable batches for formulation purposes. X-ray powder diffraction (XRPD), mid-infrared (mid-IR) spectroscopy, differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) could not detect any differences between the two samples. NIRS detected differences in the location or orientation of the water molecules within the crystal lattices.


Journal of Chromatography A | 1988

Stability-indicating high-performance liquid chromatographic analysis of tin protoporphyrin and other free acid metalloporphyrins

John F. Bauer; Cathie L. Linton; Barbara Norris

In recent years, there has been increased interest in metalloporphyrins as therapeutic agents. The iron porphyrin, hemin (I), has been found to be useful in the treatment of acute porphyria’, while tin protoporphyrin (II) shows therapeutic activity against hyperbilirubinemia in infant?. Many metalloporphyrins are subject to degradation in aqueous solution due to solution pH or exposure to light. As a result, the need for a stability-indicating assay of metalloporphyrins has increased. Although there are a number of highperformance liquid chromatographic (HPLC) methods reported in the literature3-* for porphyrins and metalloporphyrin esters, a majority of these are not widely applicable to free acid metalloporphyrins. This work reports a stability-indicating HPLC analysis for tin protoporphyrin; however, the procedure may be applicable to a variety of free acid metalloporphyrins.


Organic Process Research & Development | 2000

Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development

Sanjay R. Chemburkar; John F. Bauer; Kris C. Deming; Harry O. Spiwek; Ketan Patel; John Morris; Rodger F. Henry; Stephen G. Spanton; Walter Dziki; William Porter; John Quick; Phil Bauer; John Donaubauer; Bikshandarkoil A Narayanan; Mauro Soldani; and Dave Riley; Kathyrn McFarland


Archive | 1999

Polymorph of a pharmaceutical

John F. Bauer; Azita Saleki-Gerhardt


Journal of Pharmaceutical Sciences | 1999

Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation

John F. Bauer; Walter Dziki; John Quick


Journal of Pharmaceutical Sciences | 1983

High-Performance Liquid Chromatographic Stability-Indicating Assay for Naphazoline and Tetrahydrozoline in Ophthalmic Preparations

John F. Bauer; Suzanne Krogh


Archive | 1984

Acid salts of valproic acid

John F. Bauer; Douglas Marcel Shada


Archive | 1995

Terazosin monohydrochloride and processes and intermediate for its production

James A Morley; John F. Bauer; Ramesh F. Patel; Rodger E. Henry; Stephen G. Spanton


Journal of Pharmaceutical Sciences | 2006

Identification, Preparation, and Characterization of Several Polymorphs and Solvates of Terazosin Hydrochloride

John F. Bauer; J. Morley; S. Spanton; F.J.J. Leusen; R. Henry; S. Hollis; W. Heitmann; A. Mannino; J. Quick; W. Dziki

Collaboration


Dive into the John F. Bauer's collaboration.

Top Co-Authors

Avatar

Stephen G. Spanton

State University of New York System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge